📑Medikamentu iegade
Procurement process summary
This process is to purchase Medikamentu iegade.
This contract was awarded by 🇱🇻 Sabiedrība ar ierobežotu atbildību "VIDZEMES SLIMNĪCA" for an amount of EUR 1,727,513 to 1 supplier. It was published on 2023-05-26 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇱🇻 Sabiedrība ar ierobežotu atbildību "VIDZEMES SLIMNĪCA" Buying unitnot reported Publication date2023-05-26 Contest statusnot reported DescriptionMedikamentu iegadeAwards
This award was granted to SIA "Oribalt Rīga" by Sabiedrība ar ierobežotu atbildību "VIDZEMES SLIMNĪCA" for an amount of EUR 1,727,513. The procurement process was conducted through open for the category of goods. This is award number 12.
This contract has multiple awards. This is award number 12. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇱🇻 SIA "Oribalt Rīga" | EUR 1,727,513 | 12 |
Market context and opportunities
The execution of this contract allows the entity Sabiedrība ar ierobežotu atbildību "VIDZEMES SLIMNĪCA" to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberLV_ocds-70d2nz-0550cf24-652e-45c6-9f5f-7078ade88616-award-12Publication date2023-05-26Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
